Researchers from the University of Virginia have published the latest results from the International Diabetes Closed-Loop trial. Their findings suggest that applying a closed-loop approach to the administration of insulin in patients with type 1 diabetes could be a viable alternative to current methods. This could change the life of patients for whom the automatic and efficient monitoring of glucose levels is paramount to control the numerous complications associated with the progress of their condition.